Nanobiotix is trading 6.77% up at $41.95, rebounding after closing at $39.29 on September 1, 2026; no clear company-specific catalyst has been identified for the September 2 move.
- Its investor-relations page lists the latest 2026 release as a July 30 voting-rights filing, with no September 2 announcement shown.
- Broader markets are mixed, so the gain cannot be confidently attributed to global sentiment.